Robert A. Floyd

Biography

Dr. Floyd is co-founder and Chief Operating Officer of EpimedX and an inventor of the patents licensed to EpimedX.  The discoveries that led to development of Gene Regulation Therapy were made in Drs. Floyd and Broyles laboratories. Dr. Floyd earned a PhD from Purdue University and continued postdoctoral training in Biophysics at University of Pennsylvania and Washington University before appointment on the faculty of the Oklahoma Medical Research Foundation where he headed up the Free Radical Biology and Aging Research program for 20 years and held the Merrick Foundation Chair in Aging Research. Prior to establishing EpimedX, Dr. Floyd founded and helped develop three companies in the biotechnology sector, Centaur Pharmaceuticals, Otologic Pharmaceutics, and Onconos, LLC. Dr. Floyd’s background and experience in the biotechnology sector is of great value to EpimedX’s

Research Interest

Biotechnology